Skip to main content
Erschienen in: Zeitschrift für Gerontologie und Geriatrie 1/2016

01.01.2016 | Übersichten

Paraoxonase (PON1) polymorphisms Q192R and L55M are not associated with human longevity

A meta-analysis

verfasst von: Gan-Zhong Wei, Mei-Yan Zhu, Fang Wang, Yue-Guang Zhao, Shan-Shan Li, Tong-Yang Liu, Ying Luo, Dr. Wen-Ru Tang

Erschienen in: Zeitschrift für Gerontologie und Geriatrie | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

Genetic mutations in the paraoxonase 1 (PON1) encoding gene have been considered to affect mortality and of these the functional promoter region polymorphisms Q192R and L55M are among the most widely studied.

Objective

The aim of this study was to determine whether the Q192R and L55M polymorphisms of PON1 can increase susceptibility to longevity. A meta-analysis was performed to obtain a comprehensive estimation of the association between Q192R and L55M and longevity in long-lived individuals (LLIs) aged 80 years or more.

Material and methods

A search was carried out in the PubMed database (from January 2001 to May 2014) to obtain data on the role of PON1 polymorphisms in longevity and a pooled odds ratio (OR) with a 95 % confidence interval (CI) was used to assess the associations.

Results

The meta-analysis was based on 9 studies of PON1 Q192R and 5 studies of PON1 L55M that covered a total of 5086 LLIs and 4494 controls. Overall, significantly increased risks were not observed for either Q192R or L55M. The results of the statistical calculations were as follows: R vs. Q (additive model): OR = 1.080, 95 % CI = 0.989–1.179, p = 0.088 and RR + RQ vs. QQ (dominant model): OR = 1.099, 95 % CI = 0.975–1.240, p = 0.124; M vs. L (additive model): OR = 0.946, 95 % CI = 0.862–1.039, p = 0.245 and MM + ML vs. LL (dominant model): OR = 0.951, 95 % CI = 0.836–1.081, p = 0.442 for Q192R and L55M, respectively. The results did not change with an age cut-off among the LLIs of ≥ 93 years.

Conclusion

No evidence that the Q192R and L55M polymorphisms of PON1 impacted on the probability of reaching extreme ages was found although this cannot be completely ruled out; however, the possibility of population-specific effects due to the influence of and interaction between different genes or environmental factors could not be ruled out.
Literatur
1.
Zurück zum Zitat Rozek LS, Hatsukami TS, Richter RJ, Ranchalis J, Nakayama K, McKinstry LA, Gortner DA, Boyko E, Schellenberg GD, Furlong CE, Jarvik GP (2005) The correlation of paraoxonase (PON1) activity with lipid and lipoprotein levels differs with vascular disease status. J Lipid Res 46:1888–1895 ([IF: 4.73])PubMedCrossRef Rozek LS, Hatsukami TS, Richter RJ, Ranchalis J, Nakayama K, McKinstry LA, Gortner DA, Boyko E, Schellenberg GD, Furlong CE, Jarvik GP (2005) The correlation of paraoxonase (PON1) activity with lipid and lipoprotein levels differs with vascular disease status. J Lipid Res 46:1888–1895 ([IF: 4.73])PubMedCrossRef
2.
Zurück zum Zitat Harel M, Aharoni A, Gaidukov L, Brumshtein B, Khersonsky O, Meged R, Dvir H, Ravelli RB, McCarthy A, Toker L, Silman I, Sussman JL, Tawfik DS (2004) Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes. Nat Struct Mol Biol 11:412–419 ([IF: 11.633])PubMedCrossRef Harel M, Aharoni A, Gaidukov L, Brumshtein B, Khersonsky O, Meged R, Dvir H, Ravelli RB, McCarthy A, Toker L, Silman I, Sussman JL, Tawfik DS (2004) Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes. Nat Struct Mol Biol 11:412–419 ([IF: 11.633])PubMedCrossRef
3.
Zurück zum Zitat Rea IM, McKeown PP, McMaster D, Young IS, Patterson C, Savage MJ, Belton C, Marchegiani F, Olivieri F, Bonafe M, Franceschi C (2004) Paraoxonase polymorphisms PON1 192 and 55 and longevity in Italian centenarians and Irish nonagenarians. A pooled analysis. Exp Gerontol 39:629–635 ([IF: 3.529])PubMedCrossRef Rea IM, McKeown PP, McMaster D, Young IS, Patterson C, Savage MJ, Belton C, Marchegiani F, Olivieri F, Bonafe M, Franceschi C (2004) Paraoxonase polymorphisms PON1 192 and 55 and longevity in Italian centenarians and Irish nonagenarians. A pooled analysis. Exp Gerontol 39:629–635 ([IF: 3.529])PubMedCrossRef
4.
Zurück zum Zitat Pauk VV, Tuktarova IA, Nasibullin TR, Zueva LP, Adel’guzhina A, Khusnutdinova EK, Mustafina OE (2007) Paraoxonase 1 gene polymorphism 192Q/R in old men and long-livers from Tatars ethnic group. Mol Biol (Mosk) 41:601–607CrossRef Pauk VV, Tuktarova IA, Nasibullin TR, Zueva LP, Adel’guzhina A, Khusnutdinova EK, Mustafina OE (2007) Paraoxonase 1 gene polymorphism 192Q/R in old men and long-livers from Tatars ethnic group. Mol Biol (Mosk) 41:601–607CrossRef
5.
Zurück zum Zitat Bonafè et al. (2002) Genetic analysis of Paraoxonase (PON1) locus reveals an increased frequency of Arg192 allele in centenarians. Eur J Hum Genet 10:292–296 ([IF: 4.225])PubMedCrossRef Bonafè et al. (2002) Genetic analysis of Paraoxonase (PON1) locus reveals an increased frequency of Arg192 allele in centenarians. Eur J Hum Genet 10:292–296 ([IF: 4.225])PubMedCrossRef
6.
Zurück zum Zitat Christiansen L, Bathum L, Frederiksen H, Christensen K (2004) Paraoxonase 1 polymorphisms and survival. Eur J Hum Genet 12:843–847 ([IF: 4.225])PubMedCrossRef Christiansen L, Bathum L, Frederiksen H, Christensen K (2004) Paraoxonase 1 polymorphisms and survival. Eur J Hum Genet 12:843–847 ([IF: 4.225])PubMedCrossRef
7.
Zurück zum Zitat Novelli V, Viviani Anselmi C, Roncarati R, Guffanti G, Malovini A, Piluso G, Puca AA (2008) Lack of replication of genetic associations with human longevity. Biogerontology 9:85–92 ([IF: 3.01])PubMedCrossRef Novelli V, Viviani Anselmi C, Roncarati R, Guffanti G, Malovini A, Piluso G, Puca AA (2008) Lack of replication of genetic associations with human longevity. Biogerontology 9:85–92 ([IF: 3.01])PubMedCrossRef
8.
Zurück zum Zitat Lescai F, Marchegiani F, Franceschi C (2009) PON1 is a longevity gene: results of a meta-analysis. Ageing Res Rev 8:277–284 ([IF: 7.628])PubMedCrossRef Lescai F, Marchegiani F, Franceschi C (2009) PON1 is a longevity gene: results of a meta-analysis. Ageing Res Rev 8:277–284 ([IF: 7.628])PubMedCrossRef
9.
Zurück zum Zitat Caliebe A, Kleindorp R, Blanche H, Christiansen L, Puca AA, Rea IM, Slagboom E, Flachsbart F, Christensen K, Rimbach G, Schreiber S, Nebel A (2010) No or only population-specific effect of PON1 on human longevity: a comprehensive meta-analysis. Ageing Res Rev 9:238–244 ([IF: 7.628])PubMedCrossRef Caliebe A, Kleindorp R, Blanche H, Christiansen L, Puca AA, Rea IM, Slagboom E, Flachsbart F, Christensen K, Rimbach G, Schreiber S, Nebel A (2010) No or only population-specific effect of PON1 on human longevity: a comprehensive meta-analysis. Ageing Res Rev 9:238–244 ([IF: 7.628])PubMedCrossRef
10.
Zurück zum Zitat Hjelmborg PS, Ghisari M, Bonefeld-Jorgensen EC (2006) SPE-HPLC purification of endocrine-disrupting compounds from human serum for assessment of xenoestrogenic activity. Anal Bioanal Chem 385:875–887 ([IF: 3.578])PubMedCrossRef Hjelmborg PS, Ghisari M, Bonefeld-Jorgensen EC (2006) SPE-HPLC purification of endocrine-disrupting compounds from human serum for assessment of xenoestrogenic activity. Anal Bioanal Chem 385:875–887 ([IF: 3.578])PubMedCrossRef
11.
Zurück zum Zitat Mehdi MM, Rizvi SI (2012) Human plasma paraoxonase 1 (PON1) arylesterase activity during aging: correlation with susceptibility of LDL oxidation. Arch Med Res 43:438–443 ([IF: 2.406])PubMedCrossRef Mehdi MM, Rizvi SI (2012) Human plasma paraoxonase 1 (PON1) arylesterase activity during aging: correlation with susceptibility of LDL oxidation. Arch Med Res 43:438–443 ([IF: 2.406])PubMedCrossRef
12.
Zurück zum Zitat Mehdi MM, Rizvi SI (2013) Plasma protein hydroperoxides during aging in humans: correlation with paraoxonase 1 (PON1) arylesterase activity and plasma total thiols. Arch Med Res 44:136–141 ([IF: 2.406])PubMedCrossRef Mehdi MM, Rizvi SI (2013) Plasma protein hydroperoxides during aging in humans: correlation with paraoxonase 1 (PON1) arylesterase activity and plasma total thiols. Arch Med Res 44:136–141 ([IF: 2.406])PubMedCrossRef
13.
Zurück zum Zitat Jansen KL, Cole TB, Park SS, Furlong CE, Costa LG (2009) Paraoxonase 1 (PON1) modulates the toxicity of mixed organophosphorus compounds. Toxicol Appl Pharmacol 236:142–153PubMedPubMedCentralCrossRef Jansen KL, Cole TB, Park SS, Furlong CE, Costa LG (2009) Paraoxonase 1 (PON1) modulates the toxicity of mixed organophosphorus compounds. Toxicol Appl Pharmacol 236:142–153PubMedPubMedCentralCrossRef
14.
Zurück zum Zitat Costa LG, Vitalone A, Cole TB, Furlong CE (2005) Modulation of paraoxonase (PON1) activity. Biochem Pharmacol 69:541–550 ([IF: 4.65])PubMedCrossRef Costa LG, Vitalone A, Cole TB, Furlong CE (2005) Modulation of paraoxonase (PON1) activity. Biochem Pharmacol 69:541–550 ([IF: 4.65])PubMedCrossRef
15.
Zurück zum Zitat Marchegiani F, Marra M, Spazzafumo L, James RW, Boemi M, Olivieri F, Cardelli M, Cavallone L, Bonfigli AR, Franceschi C (2006) Paraoxonase activity and genotype predispose to successful aging. J Gerontol A Biol Sci Med Sci 61:541–546PubMedCrossRef Marchegiani F, Marra M, Spazzafumo L, James RW, Boemi M, Olivieri F, Cardelli M, Cavallone L, Bonfigli AR, Franceschi C (2006) Paraoxonase activity and genotype predispose to successful aging. J Gerontol A Biol Sci Med Sci 61:541–546PubMedCrossRef
16.
Zurück zum Zitat Capri M, Salvioli S, Sevini F, Valensin S, Celani L, Monti D, Pawelec G, De Benedictis G, Gonos ES, Franceschi C (2006) The genetics of human longevity. Ann N Y Acad Sci 1067:252–263PubMedCrossRef Capri M, Salvioli S, Sevini F, Valensin S, Celani L, Monti D, Pawelec G, De Benedictis G, Gonos ES, Franceschi C (2006) The genetics of human longevity. Ann N Y Acad Sci 1067:252–263PubMedCrossRef
17.
Zurück zum Zitat Miura Y, Sato Y, Arai Y, Abe Y, Takayama M, Toda T, Hirose N, Endo T (2011) Proteomic analysis of plasma proteins in Japanese semisuper centenarians. Exp Gerontol 46:81–85 ([IF: 3.529])PubMedCrossRef Miura Y, Sato Y, Arai Y, Abe Y, Takayama M, Toda T, Hirose N, Endo T (2011) Proteomic analysis of plasma proteins in Japanese semisuper centenarians. Exp Gerontol 46:81–85 ([IF: 3.529])PubMedCrossRef
18.
Zurück zum Zitat Gong M, Garige M, Varatharajalu R, Marmillot P, Gottipatti C, Leckey LC, Lakshman RM (2009) Quercetin up-regulates paraoxonase 1 gene expression with concomitant protection against LDL oxidation. Biochem Biophys Res Commun 379:1001–1004PubMedCrossRef Gong M, Garige M, Varatharajalu R, Marmillot P, Gottipatti C, Leckey LC, Lakshman RM (2009) Quercetin up-regulates paraoxonase 1 gene expression with concomitant protection against LDL oxidation. Biochem Biophys Res Commun 379:1001–1004PubMedCrossRef
19.
Zurück zum Zitat Jarvik GP, Tsai NT, McKinstry LA, Wani R, Brophy VH, Richter RJ, Schellenberg GD, Heagerty PJ, Hatsukami TS, Furlong CE (2002) Vitamin C and E intake is associated with increased paraoxonase activity. Arterioscler Thromb Vasc Biol 22:1329–1333PubMedCrossRef Jarvik GP, Tsai NT, McKinstry LA, Wani R, Brophy VH, Richter RJ, Schellenberg GD, Heagerty PJ, Hatsukami TS, Furlong CE (2002) Vitamin C and E intake is associated with increased paraoxonase activity. Arterioscler Thromb Vasc Biol 22:1329–1333PubMedCrossRef
20.
Zurück zum Zitat Aviram M, Dornfeld L, Rosenblat M, Volkova N, Kaplan M, Coleman R, Hayek T, Presser D, Fuhrman B (2000) Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am J Clin Nutr 71:1062–1076 ([IF: 6.918])PubMed Aviram M, Dornfeld L, Rosenblat M, Volkova N, Kaplan M, Coleman R, Hayek T, Presser D, Fuhrman B (2000) Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am J Clin Nutr 71:1062–1076 ([IF: 6.918])PubMed
21.
Zurück zum Zitat Curtin BF, Seetharam KI, Dhoieam P, Gordon RK, Doctor BP, Nambiar MP (2008) Resveratrol induces catalytic bioscavenger paraoxonase 1 expression and protects against chemical warfare nerve agent toxicity in human cell lines. J Cell Biochem 103:1524–1535 ([IF: 3.368])PubMedCrossRef Curtin BF, Seetharam KI, Dhoieam P, Gordon RK, Doctor BP, Nambiar MP (2008) Resveratrol induces catalytic bioscavenger paraoxonase 1 expression and protects against chemical warfare nerve agent toxicity in human cell lines. J Cell Biochem 103:1524–1535 ([IF: 3.368])PubMedCrossRef
22.
Zurück zum Zitat Rao MN, Marmillot P, Gong M, Palmer DA, Seeff LB, Strader DB, Lakshman MR (2003) Light, but not heavy alcohol drinking, stimulates paraoxonase by upregulating liver mRNA in rats and humans. Metabolism 52:1287–1294 ([IF: 3.611])PubMedCrossRef Rao MN, Marmillot P, Gong M, Palmer DA, Seeff LB, Strader DB, Lakshman MR (2003) Light, but not heavy alcohol drinking, stimulates paraoxonase by upregulating liver mRNA in rats and humans. Metabolism 52:1287–1294 ([IF: 3.611])PubMedCrossRef
23.
Zurück zum Zitat Thomas-MoyaE, Gianotti M, Proenza AM, Llado I (2007) Paraoxonase 1 response to a high-fat diet: gender differences in the factors involved. Mol Med 13:203–209 ([IF: 4.824]) Thomas-MoyaE, Gianotti M, Proenza AM, Llado I (2007) Paraoxonase 1 response to a high-fat diet: gender differences in the factors involved. Mol Med 13:203–209 ([IF: 4.824])
24.
Zurück zum Zitat Deakin S, Leviev I, Guernier S, James RW (2003) Simvastatin modulates expression of the PON1 gene and increases serum paraoxonase: a role for sterol regulatory element-binding protein-2. Arterioscler Thromb Vasc Biol 23:2083–2089PubMedCrossRef Deakin S, Leviev I, Guernier S, James RW (2003) Simvastatin modulates expression of the PON1 gene and increases serum paraoxonase: a role for sterol regulatory element-binding protein-2. Arterioscler Thromb Vasc Biol 23:2083–2089PubMedCrossRef
25.
Zurück zum Zitat Talmud PJ, Stephens JW, Hawe E, Demissie S, Cupples LA, Hurel SJ, Humphries SE, Ordovas JM (2005) The significant increase in cardiovascular disease risk in APOEepsilon4 carriers is evident only in men who smoke: potential relationship between reduced antioxidant status and ApoE4. Ann Hum Genet 69:613–622 ([IF: 1.926])PubMedCrossRef Talmud PJ, Stephens JW, Hawe E, Demissie S, Cupples LA, Hurel SJ, Humphries SE, Ordovas JM (2005) The significant increase in cardiovascular disease risk in APOEepsilon4 carriers is evident only in men who smoke: potential relationship between reduced antioxidant status and ApoE4. Ann Hum Genet 69:613–622 ([IF: 1.926])PubMedCrossRef
26.
Zurück zum Zitat Dietrich M, Hu Y, Block G, Olano E, Packer L, Morrow JD, Hudes M, Abdukeyum G, Rimbach G, Minihane AM (2005) Associations between apolipoprotein E genotype and circulating F2-isoprostane levels in humans. Lipids 40:329–334 ([IF: 2.353])PubMedCrossRef Dietrich M, Hu Y, Block G, Olano E, Packer L, Morrow JD, Hudes M, Abdukeyum G, Rimbach G, Minihane AM (2005) Associations between apolipoprotein E genotype and circulating F2-isoprostane levels in humans. Lipids 40:329–334 ([IF: 2.353])PubMedCrossRef
27.
Zurück zum Zitat Jofre-Monseny L, Minihane AM, Rimbach G (2008) Impact of apoE genotype on oxidative stress, inflammation and disease risk. Mol Nutr Food Res 52:131–145 ([IF: 4.909])PubMedCrossRef Jofre-Monseny L, Minihane AM, Rimbach G (2008) Impact of apoE genotype on oxidative stress, inflammation and disease risk. Mol Nutr Food Res 52:131–145 ([IF: 4.909])PubMedCrossRef
28.
Zurück zum Zitat Boesch-Saadatmandi C, Niering J, Minihane AM, Wiswedel I, Gardeman A, Wolffram S, Rimbach G (2010) Impact of apolipoprotein E genotype and dietary quercetin on paraoxonase 1 status in apoE3 and apoE4 transgenic mice. Atherosclerosis 211:110–113 ([IF: 3.971])PubMedCrossRef Boesch-Saadatmandi C, Niering J, Minihane AM, Wiswedel I, Gardeman A, Wolffram S, Rimbach G (2010) Impact of apolipoprotein E genotype and dietary quercetin on paraoxonase 1 status in apoE3 and apoE4 transgenic mice. Atherosclerosis 211:110–113 ([IF: 3.971])PubMedCrossRef
29.
Zurück zum Zitat Nebel A, Croucher PJ, Stiegeler R et al (2005) No association between microsomal triglyceride transfer protein (MTP) haplotype and longevity in humans.Proc Natl Acad Sci USA 102(22):7906–7909 Nebel A, Croucher PJ, Stiegeler R et al (2005) No association between microsomal triglyceride transfer protein (MTP) haplotype and longevity in humans.Proc Natl Acad Sci USA 102(22):7906–7909
30.
Zurück zum Zitat Campo S, Sardo MA, Trimarchi G et al (2004) Association between serum paraoxonase (PON1) genepromoter T(-107)C polymorphism, PON1 activity and HDL levels in healthy Sicilian octogenarians.Exp Gerontol 39(7):1089–1094 Campo S, Sardo MA, Trimarchi G et al (2004) Association between serum paraoxonase (PON1) genepromoter T(-107)C polymorphism, PON1 activity and HDL levels in healthy Sicilian octogenarians.Exp Gerontol 39(7):1089–1094
31.
Zurück zum Zitat Blanche H, Cabanne L, Sahbatou M, Thomas G (2001) A study of French centenarians: are ACE and APOE associated with longevity? C R Acad Sci III 324(2):129–135 Blanche H, Cabanne L, Sahbatou M, Thomas G (2001) A study of French centenarians: are ACE and APOE associated with longevity? C R Acad Sci III 324(2):129–135
32.
Zurück zum Zitat Heijmans BT, Westendorp RG, Lagaay AM et al (2000) Common paraoxonase gene variants, mortality risk and fatal cardiovascular events in elderly subjects. Atherosclerosis 149(1):91–97 Heijmans BT, Westendorp RG, Lagaay AM et al (2000) Common paraoxonase gene variants, mortality risk and fatal cardiovascular events in elderly subjects. Atherosclerosis 149(1):91–97
Metadaten
Titel
Paraoxonase (PON1) polymorphisms Q192R and L55M are not associated with human longevity
A meta-analysis
verfasst von
Gan-Zhong Wei
Mei-Yan Zhu
Fang Wang
Yue-Guang Zhao
Shan-Shan Li
Tong-Yang Liu
Ying Luo
Dr. Wen-Ru Tang
Publikationsdatum
01.01.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Zeitschrift für Gerontologie und Geriatrie / Ausgabe 1/2016
Print ISSN: 0948-6704
Elektronische ISSN: 1435-1269
DOI
https://doi.org/10.1007/s00391-015-0892-1

Weitere Artikel der Ausgabe 1/2016

Zeitschrift für Gerontologie und Geriatrie 1/2016 Zur Ausgabe

Mitteilungen der DGG

Mitteilungen der DGG

Beiträge zum Themenschwerpunkt

Alter(n), Ambivalenz und Mimikry

Beiträge zum Themenschwerpunkt

Zeitliche Ambivalenzen des Alter(n)s